SPR-based assays enable the full functional analysis of bispecific molecules

W Meschendoerfer1, C Gassner1, F Lipsmeier2

  • 1Large Molecule Research, Pharma Research and Early Development, Roche Innovation Center Munich, Germany.

Summary

Developing novel biotherapeutics like bispecific antibodies requires advanced functional characterization. New surface plasmon resonance (SPR) assays allow simultaneous or individual assessment of binding for efficient drug development.

Related Concept Videos